How to Get Wegovy Online in 2026
Wegovy (semaglutide) is Novo Nordisk's FDA-approved weekly injection for chronic weight management. Several telehealth platforms can prescribe it, but pricing, insurance navigation, and dose-availability differ significantly.
Wegovy is a once-weekly subcutaneous injection containing semaglutide 2.4 mg, approved by the FDA in 2021 for chronic weight management in adults with a BMI of 30 or higher (or 27 with a comorbidity).
Adults seeking medically supervised weight loss who meet BMI criteria and do not have a personal or family history of medullary thyroid carcinoma or MEN-2.
Most telehealth platforms require an intake form, virtual consult, and ongoing monthly fulfillment. Brand-name Wegovy ships in pre-filled pens; insurance coverage varies.
Rankings combine clinical formulary depth, pricing transparency, and shipping reliability — weighted equally and reviewed quarterly. Read the full methodology →
Providers That Prescribe Wegovy
Mainstream telehealth giant with FDA-approved GLP-1s, an insurance concierge, and prepay savings.
Flat-rate compounded GLP-1s plus brand-name Wegovy and Zepbound, with all dosages priced the same.
Board-certified primary-care telehealth with the widest brand-name GLP-1 access in this list.
Full-spectrum GLP-1 program with both compounded and brand-name access plus unlimited provider check-ins.
Flat upfront pricing with the same dose-equal cost across both compounded and brand-name GLP-1s.
Publicly traded telehealth giant with weight-loss, ED, and hair-loss programs under one roof.
Longevity-focused clinic with à la carte access to rapamycin, NAD+, LDN, and metformin protocols.
Women-focused sister brand to Hims spanning GLP-1, hair, skincare, and menopause care.
Cash-pay telehealth marketplace with transparent per-visit pricing and Costco-member discounts.
Doctor-guided GLP-1 program with both injectable and tablet options across multiple categories.
Clinician-guided GLP-1 platform with both compounded and brand-name access plus overnight shipping.
Wide compounded and brand-name catalog covering weight loss, anti-aging, and hair growth without insurance.
Personalised GLP-1 and sexual-wellness program with insurance navigation and optional nutrition coaching.
GLP-1 platform that pairs medication with one-on-one coaching and a broad off-label formulary.
Medically supervised, discreet, multi-category telehealth with a heavy compounded formulary.
GLP-1 clinic offering injections, oral semaglutide, drops, and lozenges plus brand-name Wegovy and Zepbound.
Legacy WW lifestyle program paired with brand-name GLP-1 prescriptions and clinician oversight.
GLP-1 weight-loss platform combined with personalised nutrition and fitness coaching.
What the Studies Actually Show
Wegovy is the FDA-approved brand-name semaglutide injection for chronic weight management. The figures below come from the pivotal Phase 3 trials (STEP 1, SELECT) and the current FDA prescribing information.
| Endpoint | Finding |
|---|---|
| Mean weight loss (STEP 1, 68 weeks, 2.4 mg)1 | −14.9% body weight vs −2.4% placebo in adults with overweight/obesity without diabetes |
| Cardiovascular outcomes (SELECT, ~40 months)2 | 20% relative risk reduction in major adverse cardiovascular events (MACE) in adults with established CV disease and overweight/obesity |
| GI side effects (FDA prescribing information)3 | Nausea ≥10%, diarrhea ≥10%, vomiting ≥10%, constipation ≥10%; most cases mild–moderate and dose-dependent |
| Boxed warning3 | Risk of thyroid C-cell tumors observed in rodent studies; contraindicated in personal/family history of MTC or MEN 2 |
| A1C reduction (T2D, SUSTAIN program)4 | ≈1.4–1.8% A1C reduction at 1.0 mg weekly across SUSTAIN-2 through SUSTAIN-7 head-to-head trials |
| Compounded semaglutide — evidence basis5 | Active ingredient is identical to Wegovy/Ozempic; efficacy is inferred from the active ingredient. The FDA does not formally approve compounded products; quality depends on the 503A/503B compounding pharmacy Following the FDA's 2024 ruling that ended the official tirzepatide and semaglutide shortages, compounded GLP-1s are dispensed under the personalisation exception, which requires a documented clinical justification (custom dose, B12 addition, or documented intolerance to an inactive ingredient). |
Frequently Asked Questions
Can I get Wegovy without insurance?
Yes. Several providers in our list dispense Wegovy on a cash-pay basis, though monthly cost without insurance typically ranges from $1,000 to $1,400.
Which telehealth providers prescribe Wegovy?
TMates, TrimRx, MEDVi, Eden, GetThinMD, SkinnyRx, FuturHealth, JRNYS, PlushCare, and Ro all prescribe Wegovy.
- STEP 1 — NEJM 2021 · Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 2021;384:989–1002.
- SELECT — NEJM 2023 · Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med 2023;389:2221–2232.
- FDA Prescribing Information — Wegovy (semaglutide) · WEGOVY (semaglutide) injection, for subcutaneous use. U.S. Food and Drug Administration prescribing information.
- SUSTAIN program — ADA scientific summary · Aroda VR, Ahmann A, Cariou B, et al. Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 clinical trials. Diabetes Obes Metab 2019;21(7):1601–1613.
- FDA — Compounding and the FDA: Questions and Answers · U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers (last updated 2024).
RxNotebook is an editorial publication. Citations point to peer-reviewed journals, FDA labeling, and clinical society guidelines. We are not affiliated with the studies cited above. This page is for general information and is not medical advice.